Healthpeak Properties, Inc. $DOC Shares Purchased by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. grew its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 54.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,566 shares of the real estate investment trust’s stock after acquiring an additional 3,017 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Healthpeak Properties were worth $173,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Parallel Advisors LLC increased its holdings in shares of Healthpeak Properties by 4.2% during the first quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust’s stock valued at $283,000 after acquiring an additional 561 shares in the last quarter. Applied Finance Capital Management LLC increased its holdings in shares of Healthpeak Properties by 3.4% during the first quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust’s stock valued at $357,000 after acquiring an additional 577 shares in the last quarter. AssuredPartners Investment Advisors LLC increased its holdings in shares of Healthpeak Properties by 3.1% during the first quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust’s stock valued at $447,000 after acquiring an additional 666 shares in the last quarter. Banco Bilbao Vizcaya Argentaria S.A. increased its holdings in shares of Healthpeak Properties by 4.1% during the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 18,146 shares of the real estate investment trust’s stock valued at $367,000 after acquiring an additional 722 shares in the last quarter. Finally, TCTC Holdings LLC increased its holdings in shares of Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 751 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 0.1%

Healthpeak Properties stock opened at $18.24 on Wednesday. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $23.26. The stock’s 50 day simple moving average is $17.76 and its two-hundred day simple moving average is $18.15. The firm has a market cap of $12.68 billion, a PE ratio of 76.00, a P/E/G ratio of 2.35 and a beta of 1.07.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business’s quarterly revenue was down .2% on a year-over-year basis. During the same period in the prior year, the company posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.7%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties’s dividend payout ratio is presently 508.33%.

Wall Street Analyst Weigh In

DOC has been the topic of several recent analyst reports. Wells Fargo & Company cut their price objective on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 27th. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the company an “outperform” rating in a research report on Wednesday, July 30th. Wall Street Zen lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Monday, July 7th. Evercore ISI set a $22.00 target price on Healthpeak Properties in a research report on Monday. Finally, Scotiabank lowered Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and dropped their target price for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $21.45.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker bought 2,930 shares of Healthpeak Properties stock in a transaction dated Thursday, July 31st. The stock was acquired at an average cost of $17.06 per share, with a total value of $49,985.80. Following the purchase, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. This represents a 1.41% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Over the last three months, insiders purchased 8,783 shares of company stock worth $150,129. Corporate insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.